Back to mobile site

Morgan Stanley on Pfizer (PFE): Atirmo Ph2 data an 'incremental positive'

March 17, 2026 8:39 AM EDT Send to a Friend
Morgan Stanley analyst Terence Flynn reiterated an Equalweight rating and $27.00 price target on Pfizer (NYSE: PFE)The analyst commented, "Atirmo ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login